Unresolved antiretroviral treatment management issues in HIV-infected children
- PMID: 22138766
- PMCID: PMC4825866
- DOI: 10.1097/QAI.0b013e3182427029
Unresolved antiretroviral treatment management issues in HIV-infected children
Abstract
Antiretroviral therapy in children has expanded dramatically in low-income and middle-income countries. The World Health Organization revised its pediatric HIV guidelines to recommend initiation of antiretroviral therapy in all HIV-infected children younger than 2 years, regardless of CD4 count or clinical stage. The number of children starting life-long antiretroviral therapy should therefore expand dramatically over time. The early initiation of antiretroviral therapy has indisputable benefits for children, but there is a paucity of definitive information on the potential adverse effects. In this review, a comprehensive literature search was conducted to provide an overview of our knowledge about the complications of treating pediatric HIV. Antiretroviral therapy in children, as in adults, is associated with enhanced survival, reduction in opportunistic infections, improved growth and neurocognitive function, and better quality of life. Despite antiretroviral therapy, HIV-infected children may continue to lag behind their uninfected peers in growth and development. In addition, epidemic concurrent conditions, such as tuberculosis, malaria, and malnutrition, can combine with HIV to yield more rapid disease progression and poor treatment outcomes. Additional studies are required to evaluate the long-term effects of antiretroviral therapy in HIV-infected infants, children, and adolescents, particularly in resource-limited countries where concomitant infections and conditions may enhance the risk of adverse effects. There is an urgent need to evaluate drug-drug interactions in children to determine optimal treatment regimens for both HIV and coinfections.
Conflict of interest statement
L.M.M., C.V.H., and E.K. have no competing interests.
Similar articles
-
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. MMWR Recomm Rep. 2009. PMID: 19730409 Free PMC article.
-
Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.Pediatr Infect Dis J. 2014 Jul;33(7):747-52. doi: 10.1097/INF.0000000000000226. Pediatr Infect Dis J. 2014. PMID: 24378942 Free PMC article.
-
Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis.Clin Infect Dis. 2016 Jun 15;62(12):1586-1594. doi: 10.1093/cid/ciw139. Epub 2016 Mar 21. Clin Infect Dis. 2016. PMID: 27001796 Free PMC article. Review.
-
Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.Pediatrics. 2012 Nov;130(5):e1326-44. doi: 10.1542/peds.2012-0405. Epub 2012 Oct 1. Pediatrics. 2012. PMID: 23118140 Review.
-
Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa.Med Mal Infect. 2015 May;45(5):149-56. doi: 10.1016/j.medmal.2015.03.002. Epub 2015 Apr 7. Med Mal Infect. 2015. PMID: 25861689 Review.
Cited by
-
The unmet mental health needs of adolescents with HIV in eastern Tanzania: Experiences of healthcare providers, adolescents, and caregivers.PLoS One. 2024 Aug 28;19(8):e0307143. doi: 10.1371/journal.pone.0307143. eCollection 2024. PLoS One. 2024. PMID: 39197001 Free PMC article.
-
Perceived barriers and opportunities for implementing an integrated psychological intervention for depression in adolescents living with HIV in Tanzania.BMC Health Serv Res. 2024 May 28;24(1):672. doi: 10.1186/s12913-024-11118-5. BMC Health Serv Res. 2024. PMID: 38807134 Free PMC article.
-
Bedside paediatric HIV testing in Malawi: Impact on testing rates.Malawi Med J. 2017 Sep;29(3):237-239. doi: 10.4314/mmj.v29i3.2. Malawi Med J. 2017. PMID: 29872513 Free PMC article.
-
Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e1-e8. doi: 10.1097/QAI.0000000000001163. J Acquir Immune Defic Syndr. 2017. PMID: 27570910 Free PMC article.
-
Advances in Drug Discovery and Development for Pediatric Tuberculosis.Mini Rev Med Chem. 2016;16(6):481-97. doi: 10.2174/1389557515666150722101723. Mini Rev Med Chem. 2016. PMID: 26202201 Free PMC article. Review.
References
-
- Joint United Nations Programme on HIV/AIDS (UNAIDS) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector—Progress Report 2010. Geneva, Switzerland: UNAIDS; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf. Accessed January 3, 2011.
-
- World Health Organization (WHO) Progress Report 2009. WHO; Geneva, Switzerland: 2009. Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Available at: http://www.who.int/hiv/pub/tuapr_2009_en.pdf. Accessed August 4, 2010.
-
- World Health Organization (WHO) Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. Geneva, Switzerland: WHO; 2008. Available at: http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_m.... Accessed September 10, 2010.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials